Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7563153 | 0.86 | SRD5A2 (0.55) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL9571882 | 0.85 | ALOX5 (0.62) | L3MBTL1ALDH1A1LMNAHDAC6SMN1; SMN2 | |
| SCHEMBL9571873 | 0.82 | CA2 (0.52) | ALDH1A1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4479767 | 0.80 | ALOX5 (0.57) | L3MBTL1TDP1ALDH1A1KDM4ELMNA | |
| SCHEMBL8867104 | 0.80 | HTT (0.59) | L3MBTL1ALDH1A1KDM4ELMNAKMT2A | |
| SCHEMBL29116748 | 0.80 | ALDH1A1 (0.56) | CES1CES2AKR1B1PAML3MBTL1 | |
| SCHEMBL2254547 | 0.80 | ALDH1A1 (0.60) | CES1CES2AKR1B1PAML3MBTL1 | |
| Methyl Alcohol SCHEMBL11054071 | 0.80 | CES1 (0.64) | CES1CES2AKR1B1PAML3MBTL1 | |
| SCHEMBL77563 | 0.79 | CES1 (0.70) | CES1CES2AKR1B1PAML3MBTL1 | |
| SCHEMBL8699812 | 0.79 | CES2 (0.47) | CES1CES2AKR1B1PAML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118026102-A | Photochemical synthesis method for preparing solid hydrogen peroxide compound | 四川大学 | 2024-05-14 | — | — | CN | claimed |
| EP-4688717-A1 | PALLADIUM-CATALYZED CHEMOSELECTIVE MONO-ALPHA-ARYLATION OF O-PROTECTED HYDROXYACETONE | Bayer Aktiengesellschaft (DE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024200462-A1 | PALLADIUM-CATALYZED CHEMOSELECTIVE MONO-α-ARYLATION OF O-PROTECTED HYDROXYACETONE | BAYER AKTIENGESELLSCHAFT (DE) | 2024-10-03 | — | — | WO | disclosed |
| CN-118026102-A | Photochemical synthesis method for preparing solid hydrogen peroxide compound | 四川大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-113185386-B | Rapid synthesis method of biomass-based olefin | 贵州大学 | 2023-05-30 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| CN-111662167-A | Method for isomerizing cis-anethole by catalyst | 贵州柏森香料有限公司 | 2020-09-15 | — | — | CN | disclosed |
| US-20190002846-A1 | POLYPEPTIDES HAVING DEMETHYLATING ACTIVITY | GENENCOR INTERNATIONAL B.V. (NL) | 2019-01-03 | — | — | US | disclosed |
| EP-3313999-A2 | POLYPEPTIDES HAVING DEMETHYLATING ACTIVITY | Genencor International B.V. (NL) | 2018-05-02 | — | — | EP | disclosed |
| US-9959392-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-05-01 | — | — | US | disclosed |
| US-6835853-B2 | Purification of racemic mixtures | SYNTHON BV (NL) | 2004-12-28 | — | — | US | disclosed |
| EP-1444198-A1 | PROCESS FOR RESOLUTION OF TAMSULOSIN | Synthon B.V. (NL) | 2004-08-11 | — | — | EP | disclosed |
| EP-1444199-A1 | RACEMIC TAMSULOSIN FREE BASE AND METHODS OF MAKING THE SAME | Synthon B.V. (NL) | 2004-08-11 | — | — | EP | disclosed |
| US-6599917-B1 | A squalene-synthesizing enzyme inhibitor, a cholesterol biosynthesis inhibitor and a triglyceride biosynthesis inhibitor | EISAI CO., LTD. (JP) | 2003-07-29 | — | — | US | disclosed |
| US-20030109752-A1 | Process for resolution of tamsulosin and compounds, compositons, and processes associated therewith | SYNTHON IP INC. | 2003-06-12 | — | — | US | disclosed |
| WO-2003037851-A1 | RACEMIC TAMSULOSIN FREE BASE AND METHODS OF MAKING THE SAME | SYNTHON B.V. (NL) | 2003-05-08 | — | — | WO | disclosed |
| WO-2003037850-A1 | PROCESS FOR RESOLUTION OF TAMSULOSIN | SYNTHON B.V. (NL) | 2003-05-08 | — | — | WO | disclosed |
| EP-1217001-A1 | QUINUCLIDINE COMPOUNDS AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | Eisai Co., Ltd. (JP) | 2002-06-26 | — | — | EP | disclosed |
| US-4980268-A | POLYAMIC ACID CONVERTIBLE TO POLYIMIDES | CIBA-GEIGY CORPORATION (US) | 1990-12-25 | — | — | US | disclosed |
| EP-0094256-B1 | BIOLOGICAL PROCESS FOR PRODUCING ACID PRECIPITABLE POLYMERIC LIGNIN | CHEMGEN CORPORATION (US) | 1989-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109752-A1 | Process for resolution of tamsulosin and compounds, compositons, and processes associated therewith | NPSR1, REN, PTMA | CES1 639/4885CES2 2411/4885AKR1B1 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.